Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on March 2, 2006.
Experimental Physiology (2006)
DOI: 10.1113/expphysiol.2005.032755
© The Physiological Society 2006

A more recent version of this article appeared on May 1, 2006
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
91/3/603    most recent
expphysiol.2005.032755v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molinari, C.
Right arrow Articles by Vacca, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molinari, C.
Right arrow Articles by Vacca, G.

Received November 11, 2005
Revised January 19, 2006
Accepted after revision February 27, 2006


Vascular [310]

The role of nitric oxide in the peripheral vasoconstriction caused by human placental lactogen in anaesthetized pigs

Claudio Molinari 1*, Elena Grossini 1, David ASG Mary 1, Flavio Ribichini 1, Nicola Surico 1, Giovanni Vacca 1

1 Università del Piemonte Orientale

* To whom correspondence should be addressed. E-mail: molinari{at}med.unipmn.it.


   Abstract
Regional intra-arterial infusion of human placental lactogen in anaesthetized pigs has been shown to cause coronary, renal and iliac vasoconstriction by antagonizing the vasodilatory effects of {beta}2-adrenergic receptors. Because nitric oxide is known to modulate or mediate {beta}2-adrenergic effects, the present study was planned in the same experimental model to determine the role of nitric oxide in the above vascular responses to human placental lactogen. In eight pigs anaesthetized with sodium pentobarbitone, changes in anterior descending coronary, left renal and left internal iliac blood flow caused by intra-arterial infusion of human placental lactogen at constant heart rate and arterial blood pressure were assessed using electromagnetic flowmeters. Intra-arterial infusion of the human placental lactogen caused decreases in coronary, renal and iliac blood flow which respectively averaged 16.7%, 8.1% and 12.2% of the baseline values. The role of nitric oxide in this response was studied in the same pigs by repeating the experiments, after measured blood flows had returned to baseline values, following intra-arterial administration of N{omega}-nitro-L-arginine methyl ester (L-NAME). The subsequent intra-arterial infusion of human placental lactogen did not cause any significant changes in measured blood flows, even when performed after reversing the increase in arterial blood pressure and coronary, renal and iliac resistance caused by L-NAME with continuous intravenous infusion of papaverine. These results indicate that the coronary, renal and iliac vasoconstriction caused by human placental lactogen, known to involve antagonism of {beta}2-adrenergic vasodilatory effect, was mediated by inhibition of nitric oxide release.

Key Words: Hormones, Nitric oxide, Vascular blood flow




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Molinari, E. Grossini, D. A. S. G. Mary, F. Uberti, E. Ghigo, F. Ribichini, N. Surico, and G. Vacca
Prolactin Induces Regional Vasoconstriction through the {beta}2-Adrenergic and Nitric Oxide Mechanisms
Endocrinology, August 1, 2007; 148(8): 4080 - 4090.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the The Physiological Society.